Claudia Zampaloni
Claudia Zampaloni
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,#,
Patrizio Mattei
Patrizio Mattei
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
2,#,
Konrad Bleicher
Konrad Bleicher
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
3SixPeaks Bio, Basel, Switzerland
2,3,#,
Lotte Winther
Lotte Winther
4Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
4,
Claudia Thäte
Claudia Thäte
4Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
5Preclinical Sciences and Translational Safety, Janssen Pharmaceutica, Beerse, Belgium
4,5,
Christian Bucher
Christian Bucher
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
2,
Jean-Michel Adam
Jean-Michel Adam
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
6AutoChem R&D, Mettler-Toledo International, Greifensee, Switzerland
2,6,
Alexander Alanine
Alexander Alanine
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
7Independent consultant, Cambridge, Great Britain
2,7,
Kurt E Amrein
Kurt E Amrein
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,
Vadim Baidin
Vadim Baidin
8Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA USA
8,
Christoph Bieniossek
Christoph Bieniossek
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,
Caterina Bissantz
Caterina Bissantz
4Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
4,
Franziska Boess
Franziska Boess
4Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
4,
Carina Cantrill
Carina Cantrill
4Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
4,
Thomas Clairfeuille
Thomas Clairfeuille
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
2,
Fabian Dey
Fabian Dey
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
2,
Patrick Di Giorgio
Patrick Di Giorgio
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
2,
Pauline du Castel
Pauline du Castel
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
2,
David Dylus
David Dylus
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,
Pawel Dzygiel
Pawel Dzygiel
4Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
4,
Antonio Felici
Antonio Felici
9Discovery Microbiology, Aptuit (Verona) Srl, an Evotec Company, Verona, Italy
9,
Fernando García-Alcalde
Fernando García-Alcalde
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,
Andreas Haldimann
Andreas Haldimann
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,
Matthew Leipner
Matthew Leipner
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
4Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,4,
Semen Leyn
Semen Leyn
10Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA USA
10,
Séverine Louvel
Séverine Louvel
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,
Pauline Misson
Pauline Misson
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,
Andrei Osterman
Andrei Osterman
10Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA USA
10,
Karanbir Pahil
Karanbir Pahil
8Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA USA
8,
Sébastien Rigo
Sébastien Rigo
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,
Adrian Schäublin
Adrian Schäublin
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
3SixPeaks Bio, Basel, Switzerland
2,3,
Sebastian Scharf
Sebastian Scharf
11Roche Pharma Research and Early Development, Informatics, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
11,
Petra Schmitz
Petra Schmitz
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
2,
Theodor Stoll
Theodor Stoll
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
2,
Andrej Trauner
Andrej Trauner
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,
Sannah Zoffmann
Sannah Zoffmann
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
12Therapeutics Discovery, Janssen Pharmaceutica, Beerse, Belgium
2,12,
Daniel Kahne
Daniel Kahne
8Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA USA
8,
John A T Young
John A T Young
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,
Michael A Lobritz
Michael A Lobritz
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,✉,
Kenneth A Bradley
Kenneth A Bradley
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
1,✉
1Roche Pharma Research and Early Development, Immunology, Infectious Disease and Ophthalmology, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
2Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
3SixPeaks Bio, Basel, Switzerland
4Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
5Preclinical Sciences and Translational Safety, Janssen Pharmaceutica, Beerse, Belgium
6AutoChem R&D, Mettler-Toledo International, Greifensee, Switzerland
7Independent consultant, Cambridge, Great Britain
8Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA USA
9Discovery Microbiology, Aptuit (Verona) Srl, an Evotec Company, Verona, Italy
10Infectious and Inflammatory Disease Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA USA
11Roche Pharma Research and Early Development, Informatics, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland
12Therapeutics Discovery, Janssen Pharmaceutica, Beerse, Belgium
Subject terms: Antibiotics, Pharmaceutics, Target identification
© The Author(s) 2024
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
